Medical Device Global Market Access

This episode provides a detailed overview of the mandatory requirement for medical device manufacturers to appoint a Saudi Authorized Representative (AR) to enter the market in Saudi Arabia. We explore the key responsibilities of the AR, from regulatory submissions with the Saudi Food and Drug Authority (SFDA) to post-market surveillance, and analyze the strategic advantages of appointing an indep...

This episode delves into the essential requirement for medical device manufacturers to appoint a Marketing Authorization Holder (MAH) or Local Authorized Representative to enter the United Arab Emirates market. We explore the role and responsibilities of this local partner as mandated by the Ministry of Health and Prevention (MOHAP), the strategic implications of choosing a distributor versus an i...

This episode delves into the essential role of the Marketing Authorization Holder (MAH) for medical device registration in the Philippines. We explore the regulatory requirements set by the Philippine FDA, the responsibilities of an MAH, and the critical strategic considerations for foreign manufacturers when selecting a local representative. Understanding the distinction between a distributor-as-...

Navigating the Israeli medical device market requires a deep understanding of its unique regulatory landscape. This episode provides a comprehensive overview of the Israel Registration Holder (IRH), a mandatory in-country representative for foreign manufacturers. We explore the IRH's crucial role in liaising with the AMAR (Ministry of Health), their extensive responsibilities from registration to...

This episode delves into the essential role of the License Holder (ผู้รับใบอนุญาต) for foreign medical device manufacturers entering the Thai market. We explain why appointing a local representative is mandatory under the Medical Devices Act, detailing their key responsibilities which include obtaining an Establishment License, managing product registration with the Thai FDA, and overseeing all po...

This episode delves into the essential roles of the Authorized Representative (AR) and Registrant for medical device market access in Malaysia. We clarify the legal requirements under the Medical Device Act 2012 (Act 737), explain the responsibilities of a Malaysian AR, and break down the critical strategic differences between appointing a distributor versus an independent third-party as your repr...

This episode provides a detailed overview of the mandatory Registration Number Holder (Tổ chức đứng tên đăng ký) in Vietnam for foreign medical device manufacturers. We explore the critical legal, post-market, and commercial responsibilities assigned to this local entity under the governing regulation, Decree 98/2021/ND-CP, which came into effect on January 1, 2022. Key obligations discussed inclu...

This episode demystifies the single most critical requirement for medical device manufacturers entering the Singaporean market: the local Registrant. We explore the legal framework established by the Health Products Act of 2007, defining the Registrant's non-negotiable role as the in-country representative responsible for product registration, post-market surveillance, and all communication with t...

This episode breaks down the essential role of the Authorized Indian Agent (AIA) for medical device companies entering the Indian market. We explore the regulatory framework under the CDSCO, the specifics of the MD-14 and MD-15 forms, and the critical strategic considerations when appointing your in-country representative. • What is an Authorized Indian Agent (AIA) and why is it mandatory in India...

This episode demystifies the mandatory role of the In-China Domestic Agent for foreign medical device manufacturers entering the Chinese market. We explore the legal basis under State Council Order 739, effective June 1, 2021, and detail the agent's critical responsibilities in registration, NMPA communication, post-market surveillance, adverse event reporting, and recall management. Learn why sel...

This episode demystifies the role of the Designated Marketing Authorization Holder (DMAH) for medical device companies entering Japan. We explore the critical differences between an MAH and a DMAH, outlining how the DMAH model allows foreign manufacturers to retain full ownership and control of their product approvals. Listeners will learn about the key responsibilities of a DMAH under the PMD Act...

This episode delves into the essential role of the Australian Sponsor for medical device companies seeking to enter the Australian market. We explain the legal requirements set by the Therapeutic Goods Administration (TGA), the critical responsibilities of a sponsor, and analyze the significant strategic differences between appointing a distributor versus an independent third-party sponsor. Unders...

This episode demystifies the process of entering the New Zealand medical device market by focusing on the critical role of the New Zealand Sponsor, a mandatory requirement for all overseas manufacturers. We break down the sponsor's responsibilities as mandated by Medsafe, from the initial notification in the WAND database to the crucial ongoing duties of post-market surveillance and vigilance. Thi...

This episode demystifies Canada's dual-licensing system for medical devices. We clarify the critical differences between a product-specific Medical Device Licence (MDL) for Class II-IV devices and a company-specific Medical Device Establishment Licence (MDEL) required for Class I manufacturers, importers, and distributors. Learn who needs which license, the role of the importer, and why the concep...

This episode unpacks the essential requirements for placing medical devices on the Swiss market following the lapse of the EU-Switzerland Mutual Recognition Agreement. We explore the role and legal responsibilities of the mandatory Swiss Authorised Representative (CH REP), detail the past compliance deadlines for all device and IVD classes, and explain critical labeling and registration requiremen...

This episode delves into the critical role of the European Authorised Representative (EC REP) for non-EU medical device and IVD manufacturers under the MDR and IVDR. We explore how the responsibilities have expanded beyond a simple administrative function to include significant legal liability and active compliance verification, making the choice of your EC REP a crucial strategic decision for suc...

This episode breaks down the essential post-Brexit requirement for non-UK medical device manufacturers: the UK Responsible Person (UKRP). We explore the legal obligations, key responsibilities in relation to the MHRA, and the critical role the UKRP plays in registering devices, maintaining technical documentation, and facilitating post-market surveillance for access to the market in Great Britain....

This episode provides a comprehensive guide to the Brazil Registration Holder (BRH), a mandatory requirement for foreign medical device manufacturers seeking market access in Brazil. We explore the critical role the BRH plays as the legal holder of the ANVISA registration, detailing their extensive responsibilities from initial submission to post-market surveillance. The discussion emphasizes the...

This episode breaks down the mandatory FDA requirement for foreign medical device manufacturers to appoint a U.S. Agent. We explore the specific roles, responsibilities, and qualifications of a U.S. Agent, clarifying their function as the essential communication link between your company and the FDA. Learn the key differences between a U.S. Agent and an Official Correspondent and understand the st...

This episode outlines a strategic framework for building powerful and mutually beneficial partnerships in the MedTech industry. We explore how to create a central hub for collaborators and tailor your value proposition to different partner types—from venture capitalists to distributors—all while adhering to core principles like transparency and long-term value. • How can you create a clear and eff...

This episode provides a roadmap for medical device distributors and resellers looking to add a profitable, in-demand solution to their catalog. We explore the massive growth in the global medical device market, forecast for 2024 and beyond, and break down the key elements of a successful manufacturer-distributor partnership. Learn about the value proposition, from attractive margins to products th...

In this episode, we explore a powerful partnership model for MedTech consulting firms. Discover how collaborating with Pure Global can enhance your service offerings, help you deliver tangible, data-driven results for your clients, and unlock new revenue streams for your business. We detail the dedicated support, co-marketing opportunities, and sales collateral available to our partners, positioni...

This episode is dedicated to venture capital firms invested in the medical device sector. We explore how a strategic regulatory partnership is not just an operational service but a critical tool for de-risking investments and accelerating the growth of portfolio companies. We discuss the tangible benefits of early regulatory planning, including faster market entry, enhanced capital efficiency, and...

This episode unpacks the most common and costly documentation mistakes that medical device manufacturers make in their regulatory submissions. We explore specific gaps frequently flagged by Notified Bodies and the FDA, focusing on the Clinical Evaluation Report (CER), risk management files, and Post-Market Clinical Follow-up (PMCF) plans. Learn how to identify these deficiencies in your own techni...

Choosing the right international standards is a critical strategic decision for any medical device manufacturer. This episode provides a clear framework for navigating the complex world of MedTech standards, starting with the foundational requirements for quality management (ISO 13485), risk management (ISO 14971), and software (IEC 62304). We explore how to build upon this core to select device-s...